Skip to main content
TipRanks
Go Ultimate75% OFF

Compare 3SBio (83B) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:83B3SBioEUR 1.67EUR 4.38B3.82-48.71%Strong BuyUnlock the DE:83B analyst price target with TipRanks PremiumDE:83BUnlock the DE:83B top-analyst price target with TipRanks Premium
HK:2269Wuxi Biologics (Cayman)HKD 48.88HKD 201.25B34.3746.52%Strong BuyUnlock the HK:2269 analyst price target with TipRanks PremiumDE:83B vs HK:2269Unlock the HK:2269 top-analyst price target with TipRanks Premium
HK:9926Akeso, Inc.HKD 85.65HKD 83.39B-69.98-27.23%Strong BuyUnlock the HK:9926 analyst price target with TipRanks PremiumDE:83B vs HK:9926Unlock the HK:9926 top-analyst price target with TipRanks Premium
HK:9995RemeGen Co. Ltd. Class HHKD 69.35HKD 55.77B8.43-13.96%Strong BuyUnlock the HK:9995 analyst price target with TipRanks PremiumDE:83B vs HK:9995Unlock the HK:9995 top-analyst price target with TipRanks Premium
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class HHKD 15.74HKD 31.66B-73.54-38.27%Strong BuyUnlock the HK:1877 analyst price target with TipRanks PremiumDE:83B vs HK:1877Unlock the HK:1877 top-analyst price target with TipRanks Premium
HK:2696Shanghai Henlius Biotech, Inc. Class HHKD 49.98HKD 27.20B26.74-19.13%Strong BuyUnlock the HK:2696 analyst price target with TipRanks PremiumDE:83B vs HK:2696Unlock the HK:2696 top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:83B3SBio1.67-2.01-54.57%
HK:2269Wuxi Biologics (Cayman)48.8815.5646.70%
HK:9926Akeso, Inc.85.65-33.15-27.90%
HK:9995RemeGen Co. Ltd. Class H69.35-16.10-18.84%
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class H15.74-10.10-39.09%
HK:2696Shanghai Henlius Biotech, Inc. Class H49.98-17.12-25.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts